Clinical Trial Update: Efficacy and Safety of QiShen YiQi Dripping Pills in Chronic Heart Failure [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating efficacy and safety of QiShen YiQi Dripping Pills for chronic heart failure with reduced ejection fraction has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Reduced Ejection Fraction

Drugs mentioned

• QiShen YiQi Dripping Pills

Snippet

Sponsor: Tasly Pharmaceutical Group Co., Ltd | Conditions: Chronic Heart Failure With Reduced Ejection Fraction | Phase 2 | Status: COMPLETED